華廈眼科(301267.SZ):華廈壹號已完成工商登記並完成備案手續
格隆匯9月27日丨華廈眼科(301267.SZ)發佈公吿,為促進公司未來發展,不斷擴大眼科醫療網絡佈局,公司與中電數字(北京)私募基金管理有限公司、廈門市西海創業投資有限公司、中信信託有限責任公司、廈門躍慷投資合夥企業(有限合夥)共同參與投資廈門華廈聚信壹號投資合夥企業(有限合夥)(以下簡稱“華廈壹號”)並簽署《廈門華廈聚信壹號投資合夥企業(有限合夥)合夥協議》。
近日,華廈壹號已經完成工商登記並在中國證券投資基金業協會完成備案手續,並就基金具體投資方向等情況簽署了《廈門華廈聚信壹號投資合夥企業(有限合夥)合夥協議》。根據合夥協議約定,華廈壹號已收購四川源聚愛迪眼科醫院管理有限公司51%股權,該公司控股成都愛迪眼科醫院(三甲)、恩施慧宜眼科醫院、微山醫大眼科醫院及睢寧復興眼科醫院。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.